Correction: Cost of illness of chronic kidney disease in Lebanon: from the societal and third-party payer perspectives

被引：0
|
作者：
Mabel Aoun
Elie Helou
Ghassan Sleilaty
Rony M. Zeenny
Dania Chelala
机构：
[1] Saint-Joseph University,Department of Nephrology, Faculty of Medicine
[2] Saint-George Hospital,Department of Nephrology
[3] Saint-Joseph University,Department of Urology, Faculty of Medicine
[4] Saint-Joseph University,Unit of biostatistics, Faculty of Medicine
[5] Pharmacy Director,Department of Nephrology at Hotel
[6] American University of Beirut Medical Center,Dieu de France Hospital, Faculty of Medicine
[7] Saint-Joseph University,undefined
来源：
BMC Health Services Research | / 22卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] ESTIMATING THE BUDGET IMPACT OF DAPAGLIFLOZIN FOR THE TREATMENT OF CHRONIC KIDNEY DISEASE FROM A UK PAYER PERSPECTIVE
    Darlington, Oliver
    McEwan, Phil
    Boyce, Rebecca
    Chen, Gengshi
    Martin, Becky
    Sorstadius, Elisabeth
    Sanchez, Juan Jose Garcia
    Rao, Naveen
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36 : 484 - 484
  • [42] Dosing Patterns for Duloxetine and Predictors of High-Dose Prescriptions in Patients With Major Depressive Disorder: Analysis from a United States Third-Party Payer Perspective
    Liu, Xianchen
    Cui, Zhanglin
    Niu, Liyuan
    Faries, Douglas E.
    Ball, Tamara
    Johnstone, Bryan
    CLINICAL THERAPEUTICS, 2011, 33 (11) : 1726 - 1738
  • [43] Cost effectiveness analysis of nadofaragene firadenovec for the treatment of high-risk, bacillus Calmette-Guerin-unresponsive, non-muscle invasive bladder cancer from a US third-party payer perspective
    Yang, Min
    Chai, Xinglei
    Moradi, Ashton
    Ye, Dongni
    Zhao, Angela
    Guo, Amy
    Lotan, Yair
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [44] COST OF ILLNESS AND THE FACTORS AFFECTING IT IN THE PATIENTS OF CHRONIC KIDNEY DISEASE AT A PUBLIC TERTIARY CARE HOSPITAL
    Ahlawat, R.
    Tiwari, P.
    D'Cruz, S.
    VALUE IN HEALTH, 2015, 18 (03) : A187 - A188
  • [45] INTRODUCTION OF A LOW-DOSE LEVONORGESTREL INTRAUTERINE CONTRACEPTIVE SYSTEM: A THREE-YEAR BUDGET IMPACT ANALYSIS FROM A THIRD-PARTY PAYER PERSPECTIVE IN THE UNITED STATES
    Trussell, J.
    Ferrufino, C. P.
    Hawes, C.
    Pocoski, J.
    Filonenko, A.
    Kim, R. S.
    McCoy, M. A.
    Law, A. W.
    VALUE IN HEALTH, 2013, 16 (03) : A71 - A72
  • [46] COST-UTILITY ANALYSIS OF CRIZANLIZUMAB AND HYDROXYUREA IN PREVENTING VASO-OCCLUSIVE EVENTS IN PATIENTS WITH SICKLE-CELL DISEASE: A LIFETIME MODEL FROM A PAYER'S AND SOCIETAL PERSPECTIVES
    Pontinha, V
    Almutairi, M.
    Holdford, D. A.
    VALUE IN HEALTH, 2022, 25 (01) : S91 - S91
  • [47] The cost-effectiveness of pioglitazone compared with sitagliptin: An economic evaluation using a validated economic model from a third party payer perspective in the USA
    Minshall, M.
    St. Charles, M.
    Pandya, B.
    Baran, R. W.
    Bron, M.
    VALUE IN HEALTH, 2007, 10 (06) : A259 - A259
  • [48] Recovery from established graft-vs-host disease achieved by bone marrow transplantation from a third-party allogeneic donor
    Taniguchi, Yuki
    Yoshihara, Satoshi
    Hoshida, Yoshihiko
    Inoue, Takayuki
    Fujioka, Tatsuya
    Ikegame, Kazuhiro
    Kawakami, Manabu
    Masuda, Tomoki
    Aozasa, Katsuyuki
    Kawase, Ichiro
    Ogawa, Hiroyasu
    EXPERIMENTAL HEMATOLOGY, 2008, 36 (09) : 1216 - 1225
  • [49] COST-EFECTIVENESS ANALYSIS COMPARING THE APPLICATION OR NOT OF WHOLE BRAIN IRRADIATION BEFORE STEREOTECTIC RADIOSURGERY FOR THE TREATMENT OF ONE TO FOUR BRAIN METASTASES, ACCORDING TO BRAZILIANS THIRD-PARTY PRIVATE PAYER'S PERSPECTIVE
    Santos, M.
    Stefani, S. D.
    Dias, R.
    Palma, A.
    Neto, J. P. R.
    Campos, E. S. D.
    VALUE IN HEALTH, 2012, 15 (07) : A355 - A355
  • [50] A Cost-Minimization Analysis Comparing Immediate Sequential Cataract Surgery and Delayed Sequential Cataract Surgery From the Payer, Patient, and Societal Perspectives in the United States
    Neel, Sean T.
    JAMA OPHTHALMOLOGY, 2014, 132 (11) : 1282 - 1288
12345